Advancements TV Series presentation

We invite you to learn more about our organization and lead compound, BXQ-350 through our recent Advancements TV Series Presentation

Other Videos

Chemotherapy Induced Peripheral Neuropathy (CIPN)

Immunostimulating Properties of BXQ-350

Tolerability and Preliminary Efficacy of BXQ-350 for Solid Tumors and Gliomas: First-in-human, first-in-class phase 1 trial

Comprehensive Investor Presentation

Bexion Pharmaceuticals Corporate Video

Bexion Highlight Reel

Alpha Summit Presentation

3rd Annual Glioblastoma Drug Development Presentation

Advancements TV Series presentation

BXQ-350: Stimulating the Immune System by Modulating Phosphatidylserine Expression and Sphingolipid Signaling

UCSF Awards Video

Dr. Rixe Video – BXQ-350 MOA